Meditrial CMO – Dr. Monica Tocchi joins the Venturelab Expert panel
Dr. Monica Tocchi, CMO and Founder of Meditrial joined the Innosuisse Start-up Training program designed by Venturelab, as a member of their Expert panel.
The panel is composed of successful founders, leading academic and industry partners that bring the best startups to success.
Dr. Tocchi with her 20+ years expertise in the MedTech business as a regulatory and clinical key opinion leader will support the Venturelab mentoring program. The coaching sessions are available just for the Innosuisse Start-up Training program attendants. Dr. Tocchi will share her unique knowledge and expertise with innovators from multiple sectors such as MedTech, Life Sciences, Medical devices, and Cardiovascular.
Venturelab – mandated by the Swiss Innovation Agency to IFJ the Institute for Young Entrepreneurs based in St Gallen, operates flagship startup programs such as Venture Kick, Venture Leaders, TOP 100 Swiss Startup Award, Innosuisse Start-up Trainings to support the best entrepreneurial talent.
Their programs are designed to support entrepreneurs with global ambitions, from their early-stage ideas to successful exits.
To book a coaching session, visit the Venturelab website and join their Start-up Training Programs.
Table of Contents
Build a Defensible Clinical Evidence Strategy Under EU MDR
Build a defensible clinical evidence strategy under MDR Annex XIV, from the clinical evaluation plan to PMCF and notified body review.
Getting a CE mark for medical devices: a step-by-step guide
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
A Practical RBQM Framework for Medical Device Trials
Risk-based quality management for medical device trials, with practical actions for risk assessment, monitoring, data review, and trial oversight
EU Breakthrough Medical Devices Under MDCG 2025-9 (BtX)
EU breakthrough medical devices gain a clearer regulatory pathway under MDCG 2025-9, with early advice and lifecycle evidence planning
What Swissmedic Fast-Track Means for Clinical Trial Sponsors
Swissmedic swissethics Fast-Track Pilot Project accelerates eligible trial reviews and makes coordinated regulatory preparation increasingly important.
FDA Breakthrough Device Acceleration
How innovative MedTech companies can accelerate FDA approval, secure Medicare coverage, and reach patients faster—starting with Breakthrough Device Designation.
This article provides general information and does not constitute regulatory or legal advice. Requirements should be confirmed for the specific study, applicable regulatory framework, and markets concerned.
